Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00498277 · ClinicalTrials.gov registry record
Quantitative Diffusion and Fat Imaging of the Spine
A clinical trial, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 21
- Enrollment target
NCT00498277: Completed study, sponsored by M.D. Anderson Cancer Center.
NCT00498277 is a clinical trial that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 21 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00498277 has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 21 participants
- Enrollment target
Study Summary
Primary Objective: The purpose of this study is to determine whether or not combined quantitative diffusion and fat MR imaging techniques can differentiate between benign and malignant vertebral fractures.
Interventions
- PROCEDURE Magnetic Resonance Imaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2004-08 |
| Est. Completion | 2009-07 |
What the finished NCT00498277 record still lists
NCT00498277 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 21 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Magnetic Resonance Imaging is the first listed.
NCT00498277 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00498277 about?
NCT00498277 is a clinical study titled "Quantitative Diffusion and Fat Imaging of the Spine". Primary Objective: The purpose of this study is to determine whether or not combined quantitative diffusion and fat MR imaging techniques can differentiate between benign and malignant vertebral fractures.
What is the current status of trial NCT00498277?
This trial is currently completed. The enrollment target is 21 participants. The study started on 2004-08. Estimated completion is 2009-07.
What interventions are being tested in trial NCT00498277?
The interventions under investigation include: Magnetic Resonance Imaging (PROCEDURE).
Who is sponsoring clinical trial NCT00498277?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02447874 · 21 participants · Phase 1
Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease
- NCT03826992 · 21 participants · Phase 1
Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia
- NCT04107077 · 21 participants · Phase 2
Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer
- NCT04158635 · 21 participants · Phase 1
Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia